K Pharma,Inc.

K Pharma, Inc., headquartered in Minato, Japan, was established in 2016 and operates within the Japanese market. The company is dedicated to the research, development, production, and sale of both regenerative medicines and pharmaceutical products. A key focus within their regenerative medicine efforts involves leveraging disease-specific induced pluripotent stem (iPS) cell technology, primarily to develop treatments for conditions such as spinal cord injuries and cerebral infarctions.

業界

Biotechnology

セクター

Healthcare

本社

JP

最高経営責任者（CEO）

Komei Fukushima

上場以来

2023年10月17日

従業員

20